Compare Royalty Pharma plc Class A Ordinary Shares (RPRX) vs Upstart Holdings Inc (UPST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royalty Pharma plc Class A Ordinary Shares vs Upstart Holdings Inc — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.52 (market cap $25.27B), while Upstart Holdings Inc trades at $23.92 (market cap $2.35B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 10.8× Upstart Holdings Inc's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Upstart Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 0 Days and Upstart Holdings Inc for 39 Days on average.
| RPRX | UPST | |
|---|---|---|
Market Cap | $25.27B | $2.35B |
Volume | 3,671,183 | 4,203,337 |
Sector | Health | Financials |
52-Week High | $63.96 | $52.74 |
52-Week Low | $35.44 | $22.81 |
Typical Hold Time | 0 Days | 39 Days |
Enterprise Value | $32.50B | $3.88B |
Dividend Yield | 1.66% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Upstart Holdings (UPST) trades at $24.02, up 0.67% with mixed technical signals showing bearish momentum but neutral oscillators. The company reported revenue growth to $1.02B in 2025 with a return to profitability ($53.6M net income), though recent quarters show earnings misses. Analyst sentiment is divided with a $39.50 consensus target, while recent news highlights partnership expansions and sector volatility affecting consumer lending stocks.
The outlook balances AI-driven lending growth against credit market risks and earnings volatility. Investment opportunity lies in valuation upside if execution improves, but risks include debt levels rising to 61.48% of assets and consistent earnings underperformance. The stock's proximity to recent lows suggests cautious investor sentiment amid sector headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →About Upstart Holdings Inc
Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. The revenue of the company is primarily comprised of fees paid by banks.
Read more on UPST →
